Israel News Beep | NewsBeep.com
  • News Beep
  • Israel
  • Headlines
  • Business
  • Entertainment
  • Health
  • Science
  • Sports
  • Technology
Israel News Beep | NewsBeep.com
Israel News Beep | NewsBeep.com
  • News Beep
  • Israel
  • Headlines
  • Business
  • Entertainment
  • Health
  • Science
  • Sports
  • Technology

Browsing Tag

Clinical Trials & Medical Discoveries

12 posts
MMedication
New composite outcomes data show patients treated with Lilly's Omvoh (mirikizumab-mrkz) achieved comprehensive corticosteroid-free disease control in ulcerative colitis and corticosteroid-free deep remission in Crohn's disease at one year
Read More

New composite outcomes data show patients treated with Lilly’s Omvoh (mirikizumab-mrkz) achieved comprehensive corticosteroid-free disease control in ulcerative colitis and corticosteroid-free deep remission in Crohn’s disease at one year

  • October 15, 2026
In LUCENT-2, more than one in four (27.7%) Omvoh-treated patients with ulcerative colitis achieved comprehensive disease control, a…
MMedication
Lilly's triple agonist, retatrutide, delivered substantial weight loss and A1C reduction, underscoring its potential promise for people with obesity and type 2 diabetes
Read More

Lilly’s triple agonist, retatrutide, delivered substantial weight loss and A1C reduction, underscoring its potential promise for people with obesity and type 2 diabetes

  • September 30, 2026
In TRIUMPH-2, participants with obesity and type 2 diabetes taking retatrutide 12 mg lost an average of 49.6…
HHealthcare
Oracle and Buck Institute for Research on Aging Advance Landmark Federal Aging Research Initiative
Read More

Oracle and Buck Institute for Research on Aging Advance Landmark Federal Aging Research Initiative

  • September 24, 2026
Buck Institute aims to advance bioinformatics using Oracle Life Sciences Data Intelligence to transform aging research into a…
HHealth
Bio Preventive Medicine and Precision Diabetes Announce ADA Late-Breaking Presentation Highlighting DNlite™ in Landmark CREDENCE Trial
Read More

Bio Preventive Medicine and Precision Diabetes Announce ADA Late-Breaking Presentation Highlighting DNlite™ in Landmark CREDENCE Trial

  • June 6, 2026
New analysis supports DNlite™ for earlier renal risk stratification in patients with type 2 diabetes and chronic kidney…
HHealth
First Dual GLP-1/GIP Receptor Agonist Developed for Type 1 Diabetes Shows Promising Benefits in Blood Glucose Control
Read More

First Dual GLP-1/GIP Receptor Agonist Developed for Type 1 Diabetes Shows Promising Benefits in Blood Glucose Control

  • June 5, 2026
Phase 2 Study Results Highlight Use of Once-Daily Injection for Weight Loss and Reduction in Insulin Use NEW…
MMedication
Lilly launches new "Brain Health Matters" campaign in partnership with Julianne Moore, empowering the public to prioritize brain health
Read More

Lilly’s Foundayo and lower-dose Zepbound helped people maintain weight loss after switching from higher doses of injectable incretin therapy in two late-phase trials

  • May 17, 2026
In ATTAIN-MAINTAIN, participants who transitioned from a maximum tolerated dose (MTD) of Wegovy (semaglutide) to Foundayo maintained all…
HHealthcare
Creatv Bio Opens CLIA-Certified Laboratory to Support Oncology Drug Development
Read More

Creatv Bio Opens CLIA-Certified Laboratory to Support Oncology Drug Development

  • May 13, 2026
MONMOUTH JUNCTION, N.J., May 13, 2026 /PRNewswire/ — Creatv Bio, a Division of Creatv MicroTech, Inc. (“Creatv”), a…
HHealth
Delphi Diagnostics Announces New Publication in the European Journal of Cancer
Read More

Delphi Diagnostics Announces New Publication in the European Journal of Cancer

  • May 7, 2026
Peer-reviewed manuscript demonstrates the Endocrine Activity IndexTM Recurrence Risk (EAIRR) enhances risk stratification beyond Recurrence Score® and is predictive…
HHealth
AllRock Bio Doses First Patients in Phase 2a Trial of ROC-101 for Pulmonary Hypertension
Read More

AllRock Bio Doses First Patients in Phase 2a Trial of ROC-101 for Pulmonary Hypertension

  • April 9, 2026
Phase 2a ROCSTAR study is evaluating ROC-101, a potential first-in-class oral pan-ROCK inhibitor, in PAH and ILD-PH patients…
HHealth
Avant Technologies and Austrianova Advancing α-Klotho Cell Therapy as Mayo Clinic Study Links Low α-Klotho Levels to Poor Cardiovascular Survival
Read More

Avant Technologies and Austrianova Advancing α-Klotho Cell Therapy as Mayo Clinic Study Links Low α-Klotho Levels to Poor Cardiovascular Survival

  • December 9, 2025
LAS VEGAS, Dec. 9, 2025 /PRNewswire/ — Avant Technologies, Inc. (OTCQB: AVAI) (“Avant” or the “Company”), an emerging biotechnology…
BBusiness
Curis Provides Updated Data from its Frontline AML Triplet Study
Read More

Curis Provides Updated Data from its Frontline AML Triplet Study

  • December 9, 2025
5 of 8 patients (62.5%) achieved Undetectable MRD (uMRD) LEXINGTON, Mass., Dec. 9, 2025 /PRNewswire/ — Curis, Inc.…
HHealthcare
FDA Issues Formal Guideline Waiving Clinical Efficacy Studies for Biosimilars, Confirming Professor Niazi's 15-Year Campaign to Cut Biologic Drug Costs
Read More

FDA Issues Formal Guideline Waiving Clinical Efficacy Studies for Biosimilars, Confirming Professor Niazi’s 15-Year Campaign to Cut Biologic Drug Costs

  • October 30, 2025
A Landmark Regulatory Shift Validates Professor Sarfaraz K. Niazi’s Vision to Make Biologics as Affordable as Generics CHICAGO,…
Israel News Beep | NewsBeep.com
www.newsbeep.com